Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

No pharmaceutical industry blackout

Executive Summary

Pharmaceutical companies maintained "critical" business operations during a blackout affecting parts of the Northeast and Midwest on Aug. 14 and 15. Pfizer said it implemented its "snow day" plan, meaning only "critical users" reported to the company's R&D headquarters in Groton, Conn. and an Ann Arbor, Mich. facility. Diesel generators supplied power to both facilities, keeping critical manufacturing and "temperature specific" experiments operational. Pfizer's Manhattan headquarters was closed Aug. 15. Novartis and Roche, both with U.S. operations headquartered in New Jersey, said R&D and manufacturing maintained "full capacity" both days. Merck and Schering-Plough both said their New Jersey facilities were not affected by the power outages...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS042328

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel